Hikma Pharmaceuticals PLC
OTC:HKMPF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
H
|
Hikma Pharmaceuticals PLC
OTC:HKMPF
|
UK |
|
Peruvian Metals Corp
F:6D71
|
CA |
|
Synlait Milk Ltd
NZX:SML
|
NZ |
|
Fortune Brands Innovations Inc
NYSE:FBIN
|
US |
|
S
|
Sirius XM Holdings Inc
SWB:3HY
|
US |
|
T
|
Teleperformance SE
SWB:RCF
|
FR |
|
C
|
Chesnara PLC
OTC:CSNRF
|
UK |
|
S
|
Sixt SE
OTC:SIXGF
|
DE |
|
G
|
Gen Digital Inc
SWB:SYM
|
US |
|
K
|
Koala Company Ltd
ASX:KOA
|
AU |
|
E
|
Excellence SA
F:8XY
|
PL |
|
Spearmint Resources Inc
OTC:SPMTF
|
CA |
|
P
|
Peruvian Metals Corp
OTC:DUVNF
|
CA |
|
S
|
Sidney Resources Corp
OTC:SDRC
|
US |
|
Vhm Ltd
OTC:VHMLF
|
AU |
|
D
|
Domino's Pizza Enterprises Ltd
F:HQX
|
AU |
|
C
|
Canadian Spirit Resources Inc
OTC:CSPUF
|
CA |
Bankruptcy Probability
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Hikma Pharmaceuticals PLC Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| UK |
|
Hikma Pharmaceuticals PLC
LSE:HIK
|
3.5B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Eli Lilly and Co
NYSE:LLY
|
1.1T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
643.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
355B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Roche Holding AG
OTC:RHHBF
|
345.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
216.4B CHF |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
188.2B GBP |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| CA |
|
Nuvo Pharmaceuticals Inc
TSX:MRV
|
262.4B CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.2T DKK |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
157B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
130.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Hikma Pharmaceuticals PLC's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Hikma Pharmaceuticals PLC has total debt of 1.5B USD. This includes both short-term (0 USD) and long-term (1.5B USD) debt.
You can find a full breakdown on its Balance Sheet.